
Pliant Therapeutics
Get Full AccessDescription
- Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. Pliants co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
-
Headquarters:260 Littlefield Avenue , South San Francisco, California, United States
More -
Phone Number: +1 650-481-6770
-
Website: https://www.pliantrx.com
-
Employees:79
-
Revenue:$10 - 50M
-
Legal Name:Pliant Therapeutics
-
Pliant Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Pliant Therapeutics
-
Where are Pliant Therapeutics's Headquarters?
Pliant Therapeutics's Headquarters are in 260 Littlefield Avenue ,South San Francisco,California,United States
-
What is Pliant Therapeutics's phone number?
Pliant Therapeutics's phone number is +1 650-481-6770
-
What is Pliant Therapeutics's official website?
Pliant Therapeutics's official website is https://www.pliantrx.com
-
What is Pliant Therapeutics's Revenue?
Pliant Therapeutics's revenue is $10 - 50M
-
What is Pliant Therapeutics's NAICS code?
Pliant Therapeutics's NAICS code is 325412
-
How many employees are working in Pliant Therapeutics
Pliant Therapeutics has 79 employees
-
What is Pliant Therapeutics's Industry?
Pliant Therapeutics is in the industry of Pharmaceuticals
-
Who is Pliant Therapeutics's CEO?
Pliant Therapeutics's CEO is Bernard Coulie